PharVision Advisers’s Shoe Station Group SHOE Stock Holding History

PharVision Advisers’s Portfolio SHOE Stock Details SHOE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-13,415	Closed	-$226K	–	548
2025 Q4	$226K	Buy	+13,415	New	+$246K	0.11%	458

Other funds holding SHOE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

NSCM

New South Capital Management Memphis, Tennessee $2.09B AUM 33.67% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Nokomis Capital Dallas, Texas $349M AUM 75.66% 1-Year Est. Return

PharVision Advisers's SHOE Position: Q1 2026 in Review

PharVision Advisers sold out of Shoe Station Group (SHOE) in Q1 2026, closing a stake of 13,415 shares — an estimated $226K sold.

PharVision Advisers first reported a position in SHOE in Q4 2025 and held it in 1 quarter. The position peaked at $226K in Q4 2025. 158 funds tracked by Wall St. Rank hold SHOE as of Q1 2026.

PharVision Advisers reported no remaining Shoe Station Group position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 13,415 Shoe Station Group shares in Q1 2026, an estimated $226K.
PharVision Advisers first reported a position in Shoe Station Group in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Shoe Station Group position peaked at $226K in Q4 2025.
158 funds tracked by Wall St. Rank held Shoe Station Group as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.